![Erin Lavelle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erin Lavelle
Direttore/Membro del Consiglio presso
JADE BIOSCIENCES, INC.
Patrimonio netto: - $ in data 30/06/2026
Profilo
Ms. Erin M.
Lavelle is an Independent Director at Jade Biosciences, Inc. and an Independent Director at Avalyn Pharma, Inc. She is on the Board of Directors at Jade Biosciences, Inc., Jade Biosciences, Inc. (United States) and Avalyn Pharma, Inc. Ms. Lavelle was previously employed as an Executive VP, Chief Operating & Financial Officer by Eliem Therapeutics, Inc., an Independent Director by Neoleukin Therapeutics, Inc., a Chief Operating Officer by Lundbeck Seattle BioPharmaceuticals, Inc., and a General Manager by Amgen, Inc. She also served on the board at Vitaeris, Inc. She received her undergraduate degree from Yale University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
AVALYN PHARMA INC -.--% | 30/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Posizioni attive di Erin Lavelle
| Società | Posizione | Inizio |
|---|---|---|
| JADE BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 28/04/2025 |
| AVALYN PHARMA INC. | Direttore/Membro del Consiglio | 01/07/2024 |
Precedenti posizioni note di Erin Lavelle
| Società | Posizione | Fine |
|---|---|---|
| CLIMB BIO, INC. | Direttore Finanziario/CFO | 10/03/2023 |
| ALDER BIOPHARMACEUTICALS, INC. | Direttore operativo | 01/02/2020 |
| AMGEN INC. | Corporate Officer/Principal | 01/03/2018 |
Vitaeris, Inc.
 Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Direttore/Membro del Consiglio | - |
| NEUROGENE INC. | Direttore/Membro del Consiglio | - |
Formazione di Erin Lavelle
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
83
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Avalyn Pharma Inc.
 Avalyn Pharma Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops inhaled therapies to treat rare respiratory & interstitial lung diseases | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Develops new treatment options for chronic inflammatory diseases | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
